
E37: Errik Anderson on Co-Founding 20 Biotech Startups Cumulatively Worth $10B+
Errik Anderson sits down with David Weisburd to discuss Pro-noia, the potential of the biotech industry, and the 82VS Seed Fund investment approach. They discuss practicing Pro-noia, the value of building a portfolio of relationships, and the idea of a forever company.
Key Points
- The importance of pronoia, a mindset of believing that people are conspiring for your success rather than against you.
- Approaches to biotech innovation involves creating a startup factory model that mitigates common industry risks by focusing on the unique 10% of each company.
- Alloy Therapeutics aim to revolutionize drug discovery by leveraging shared infrastructure and reinvesting 100% of their revenue into continuous innovation and access.
Chapters
| 0:00 | |
| 0:20 | |
| 0:49 | |
| 3:28 | |
| 7:47 | |
| 12:36 | |
| 18:15 | |
| 20:22 | |
| 22:45 | |
| 25:33 | |
| 32:00 | |
| 37:33 | |
| 45:49 | |
| 49:26 | |
| 53:54 | |
| 59:10 | |
| 1:00:42 | |
| 1:00:56 |
Transcript
Loading transcript...
- / -


